Rhinoviruses

Fields Virology: Sixth Edition

Volumn 1, Issue , 2013, Pages

  Gern, James E ^a,b   Palmenberg, Ann C ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UW American Family Children's Hospital   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897504634     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (263)

1. Rhinoviruses: a numbering system. Nature 1967;213:761-762.
2. A collaborative report: rhinoviruses-extension of the numbering system. Virology 1971;43:524-526.
3. Federal Drug Administration. Information on Zicam Cold Remedy Nasal Gel, Zicam Cold Remedy Nasal Swabs, and Zicam Cold Remedy Swabs, Kids Size. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm166834.htm.
4. Alper CM, Doyle WJ, Skoner DP, et al. Prechallenge antibodies: moderators of infection rate, signs, and symptoms in adults experimentally challenged with rhinovirus type 39. Laryngoscope 1996;106:1298-1305.
5. Alper CM, Winther B, Mandel EM, et al. Rate of concurrent otitis media in upper respiratory tract infections with specific viruses. Arch Otolaryngol Head Neck Surg 2009;135:17-21.
6. Amineva SP, Aminev AG, Palmenberg AC, et al. Rhinovirus 3C protease precursors 3CD and 3CD' localize to the nuclei of infected cells. J Gen Virol 2004;85:2969-2979.
7. Andries K, Dewindt B, Snoeks J, et al. Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J Virol 1990;64:1117-1123.
8. Arden KE, Mackay IM. Newly identified human rhinoviruses: molecular methods heat up the cold viruses. Rev Med Virol 2010;20:156-176.
9. Arola M, Ruuskanen O, Ziegler T, et al. Clinical role of respiratory virus infection in acute otitis media. Pediatr 1990;86:848-855.
10. Arruda E, Boyle TR, Winther B, et al. Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. J Infect Dis 1995;171:1329-1333.
11. Arruda E, Mifflia TE, Gwaltney JM Jr, et al. Localization of rhinovirus replication in vitro with in situ hybridization. J Med Virol 1991;54:634-638.
12. Arruda E, Pitkaranta A, Witek TJJ, et al. Frequency and natural history of rhinovirus infections in adults during autumn. J Clin Microbiol 1997;35:2864-2868.
13. Atmar RL, Guy E, Guntupalli KK, et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Int Med 1998;158:2453-2459.
14. Atzl I, Helms R. A short history of the common cold. In: Eccles R, ed. Common Cold. Birkhauser Verlag: Basel, Switzerland; 2009:1-21.
15. Barrett B, Brown R, Rakel D, et al. Echinacea for treating the common cold: a randomized trial. Ann Intern Med 2010;153:769-777.
16. Barrett B, Brown R, Voland R, et al. Relations among questionnaire and laboratory measures of rhinovirus infection. Eur Respir J 2006;28:358-363.
17. Bartlett NW, Walton RP, Edwards MR, et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med 2008;14:199-204.
18. Beem M. Rhinovirus infections in nursery school children. J Pediatr 1969;74:818.
19. Binder M, Eberle F, Seitz S, et al. Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I). J Biol Chem 2011;286:27278-27287.
20. Bizzintino J, Lee WM, Laing IA, et al. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J 2011;37(5)1037-1042.
21. Blair HT, Greenberg SB, Stevens PM, et al. Effects of rhinovirus infection on pulmonary function of healthy human volunteers. Am Rev Respir Dis 1976;114:95-102.
22. Bochkov YA, Hanson KM, Keles S, et al. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol 2010;3:69-80.
23. Bochkov YA, Palmenberg AC, Lee WM, et al. Molecular modeling, organ culture and reverse genetics for the emerging respiratory pathogen human rhinovirus C. Nat Med 2011;17:627-632.
24. Brockman-Schneider RA, Amineva SP, Bulat MV, et al. Serial culture of murine primary airway epithelial cells and ex vivo replication of human rhinoviruses. J Immunol Methods 2008;339:264-269.
25. Buchman CA, Doyle WJ, Pilcher O, et al. Nasal and otologic effects of experimental respiratory syncytial virus infection in adults. Am J Otolaryngol 2002;23:70-75.
26. Calvo C, Pozo F, Garcia-Garcia M, et al. Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study. Acta Paediatr 2010;99(6):883-887.
27. Casasnovas JM, Springer TA. Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): An intermediate in which ICAM-1 is bound and RNA is released. J Virol 1994;68:5882-5889.
28. Cate TR, Couch RB, Johnson KM. Studies with rhinoviruses in volunteers: production of illness, effect of naturally acquired antibody, and demonstration of a protective effect not associated with serum antibody. J Clin Invest 1964;43:56-67.
29. Chantzi FM, Papadopoulos NG, Bairamis T, et al. Human rhinoviruses in otitis media with effusion. Pediatr Allergy Immunol 2006;17:514-518.
30. Chauhan AJ, Inskip HM, Linaker CH, et al. Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children. Lancet 2003;361:1939-1944.
31. Chen Y, Hamati E, Lee PK, et al. Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. Am J Respir Cell Mol Biol 2006;34:192-203.
32. Chonmaitree T, Revai K, Grady JJ, et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis 2008;46:815-823.
33. Christiansen SC, Eddleston J, Bengtson SH, et al. Experimental Rhinovirus Infection Increases Human Tissue Kallikrein Activation in Allergic Subjects. Int Arch Allergy Immunol 2008;147:299-304.
34. Cohen S. Psychological stress and susceptibility to upper respiratory infections. Am J Respir Crit Care Med 1995;152:S53-S58.
35. Collinson J, Nicholson KG, Cancio E, et al. Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax 1996;51:1115-1122.
36. Contoli M, Message SD, Laza-Stanca V, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006;12:1023-1026.
37. Cordey S, Gerlach D, Junier T, et al. The cis-acting replication elements define human enterovirus and rhinovirus species. RNA 2008;14:1568-1578.
38. Cordey S, Junier T, Gerlach D, et al. Rhinovirus genome evolution during experimental human infection. PLoS One 2010;5:e10588.
39. Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002;359:831-834.
40. Couch RB, Douglas RG Jr, Lindgren KM, et al. Airborne transmission of respiratory infection with coxsackievirus A type 21. Am J Epidemiol 1970;91:78-86.
41. D'Alessio DJ, Meschievitz CK, Peterson JA, et al. Short-duration exposure and the transmission of rhinoviral colds. J Infect Dis 1984;150:189-194.
42. D'Alessio DJ, Peterson JA, Dick CR, et al. Transmission of experimental rhinovirus colds in volunteer married couples. J Infect Dis 1976;133:28-36.
43. de Gouw HW, Grünberg K, Schot R, et al. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir J 1998;11:126-132.
44. De SD, Dagher H, Ghildyal R, et al. Vascular endothelial growth factor induction by rhinovirus infection. J Med Virol 2006;78:666-672.
45. DeMore JP, Weisshaar EH, Vrtis RF, et al. Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. J Allergy Clin Immunol 2009;124:245-252.
46. Denlinger LC, Shi L, Guadarrama A, et al. Attenuated P2×7 pore function as a risk factor for virus-induced loss of asthma control. Am J Respir Crit Care Med 2009;179:265-270.
47. Dick EC, Blumer CR, Evans AS. Epidemiology of infections with rhinoviruses type 43 and 5 in a group of University of Wisconsin student families. Am J Epidemiol 1967;86:386-400.
48. Dick EC, Hossain SU, Mink KA, et al. Interruption of transmission of rhinovirus colds among human volunteers using virucidal paper handkerchiefs. J Infect Dis 1986;153:352-356.
49. Dick EC, Jennings LC, Mink KA, et al. Aerosol transmission of rhinovirus colds. J Infect Dis 1987;156:442-448.
50. Dochez AR, Shibley GS, Mills KC. Studies in the common cold: IV. Experimental transmission of the comon cold to anthropoid apes and human beings by means of a filtrable agent. J Exp Med 1930;52:701-716.
51. Dominguez SR, Briese T, Palacios G, et al. Multiplex MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade. J Clin Virol 2008;43:219-222.
52. Dosanjh A. Transforming growth factor-beta expression induced by rhinovirus infection in respiratory epithelial cells. Acta Biochim Biophys Sin (Shanghai) 2006;38:911-914.
53. Douglas RC Jr, Couch RB, Lindgren KM. Cold doesn't affect the "common cold" in study of rhinovirus infections. JAMA 1967;199:29-30.
54. Douglas RG Jr, Cate TR, Gerone PJ, et al. Quantitative rhinovirus shedding patterns in volunteers. Am Rev Respir Dis 1966;94:159-167.
55. Douglas RM, Hemila H, Chalker E, et al. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2007:CD000980.
56. Doyle WJ, Skoner DP, Fireman P, et al. Rhinovirus 39 infection in allergic and nonallergic subjects. J Allergy Clin Immunol 1992;89:968-978.
57. Duff AL, Pomeranz ES, Gelber LE, et al. Risk factors for acute wheezing in infants in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatr 1993;92:535-540.
58. Duits LA, Nibbering PH, van Strijen E, et al. Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol Med Microbiol 2003;38:59-64.
59. Eccles R, Eriksson M, Garreffa S, et al. The nasal decongestant effect of xylometazoline in the common cold. Am J Rhinol 2008;22:491-496.
60. Edwards MR, Hewson CA, Laza-Stanca V, et al. Protein kinase R, IkappaB kinase-beta and NF-kappaB are required for human rhinovirus induced pro-inflammatory cytokine production in bronchial epithelial cells. Mol Immunol 2007;44:1587-1597.
61. Eggleston PA, Hendley JO, Gwaltney JM Jr. Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinovirus infection. Acta Otolaryngol Suppl 1984;413:25-35.
62. Falsey AR, Treanor JJ, Betts RF, et al. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc 1992;40:115-119.
63. Farr BM, Gwaltney JM Jr, Adams KF, et al. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds. Antimicrob Agents Chemother 1984;26:31-34.
64. Ferguson EA, Eccles R. Changes in nasal nitric oxide concentration associated with symptoms of common cold and treatment with a topical nasal decongestant. Acta Otolaryngol 1997;117:614-617.
65. Fleet WF, Couch RB, Cate TR, et al. Homologous and heterologous resistance to rhinovirus common cold. Am J Epidemiol 1965;82:185-196.
66. Fox JP, Cooney MK, Hall CE, et al. Rhinoviruses in Seattle families, 1975-1979. Am J Epidemiol 1985;122:830-846.
67. Gama RE, Horsnell PR, Hughes PJ, et al. Amplification of rhinovirus specific nucleic acids from clinical samples using the polymerase chain reaction. J Med Virol 1989;28:73-77.
68. Garbino J, Soccal PM, Aubert JD, et al. Respiratory viruses in bronchoalveolar lavage: a hospital-based cohort study in adults. Thorax 2009;64:399-404.
69. Gavala ML, Bertics PJ, Gern JE. Rhinoviruses, allergic inflammation, and asthma. Immunol Rev 2011;242:69-90.
70. Gentile DA, Fireman P, Skoner DP. Elevations of local leukotriene C4 levels during viral upper respiratory tract infections. Ann Allergy Asthma Immunol 2003;91:270-274.
71. Gern JE, Dick EC, Kelly EA, et al. Rhinovirus-specific T cells recognize both shared and serotype-restricted viral epitopes. J Infect Dis 1997;175:1108-1114.
72. Gern JE, Dick EC, Lee WM, et al. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol 1996;156:621-627.
73. Gern JE, Galagan DM, Jarjour NN, et al. Detection of rhinovirus RNA in lower airway cells during experimentally-induced infection. Am J Respir Crit Care Med 1997;155:1159-1161.
74. Gern JE, Vrtis R, Grindle KA, et al. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 2000;162:2226-2231.
75. Ghildyal R, Dagher H, Donninger H, et al. Rhinovirus infects primary human airway fibroblasts and induces a neutrophil chemokine and a permeability factor. J Med Virol 2005;75:608-615.
76. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009;169:384-390.
77. Green RM, Cusotvic A, Sanderson G, et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. Br Med J 2002;324:763-766A.
78. Greve JM, Davis G, Meyer AM, et al. The major human rhinovirus receptor is ICAM-1. Cell 1989;56:839-847.
79. Grünberg K, Smits HH, Timmers MC, et al. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 1997;156:609-616.
80. Gwaltney JM Jr. Rhinoviruses. Yale J Biol Med 1975;48:17-45.
81. Gwaltney JM Jr, Hendley JO. Transmission of experimental rhinovirus infection by contaminated surfaces. Am J Epidemiol 1982;116:828-833.
82. Gwaltney JM Jr, Hendley JO, Simon G, et al. Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med 1966;275:1261-1268.
83. Gwaltney JM Jr, Moskalski PB, Hendley JO. Hand-to-hand transmission of rhinovirus colds. Ann Intern Med 1978;88:463-467.
84. Gwaltney JM, Park J, Paul RA, et al. Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds. Clin Infect Dis 1996;22:656-662.
85. Gwaltney JM Jr, Phillips CD, Miller RD, et al. Computed tomographic study of the common cold. N Engl J Med 1994;330:25-30.
86. Hakonarson H, Carter C, Maskeri N, et al. Rhinovirus-mediated changes in airway smooth muscle responsiveness: induced autocrine role of interleukin-1beta. Am J Physiol 1999;277:L13-L21.
87. Hall DJ, Bates ME, Guar L, et al. The role of p38 MAPK in rhinovirus-induced monocyte chemoattractant protein-1 production by monocytic-lineage cells. J Immunol 2005;174:8056-8063.
88. Hamparian VV, Colonno RJ, Cooney MK, et al. A collaborative report: rhinoviruses-extension of the numbering system from 89 to 100. Virology 1987;159:191-192.
89. Han TH, Chung JY, Hwang ES, et al. Detection of human rhinovirus C in children with acute lower respiratory tract infections in South Korea. Arch Virol 2009;154:987-991.
90. Handzel ZT, Busse WW, Sedgwick JB, et al. Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol 1998;160:1279-1284.
91. Harris JR, Racaniello VR. Changes in rhinovirus protein 2C allow efficient replication in mouse cells. J Virol 2003;77:4773-4780.
92. Hayden FG, Albrecht JK, Kaiser DL, et al. Prevention of natural colds by contact prophylaxis with intranasal alpha2-interferon. N Engl J Med 1986;314:71-75.
93. Hayden FG, Coats T, Kim K, et al. Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials. Antivir Ther 2002;7:53-65.
94. Hayden FG, Gwaltney JM Jr. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds. J Infect Dis 1984;150:174-180.
95. Hayden FG, Herrington DT, Coats TL, et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clin Infect Dis 2003;36:1523-1532.
96. Hayden FG, Turner RB, Gwaltney JM, et al. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother 2003;47:3907-3916.
97. Hendley JO. The host response, not the virus, causes the symptoms of the common cold. Clin Infect Dis 1998;26:847-848.
98. Hendley JO, Gwaltney JM Jr, Jordan WS Jr. Rhinovirus infections in an industrial population. IV. Infections within families of employees during two fall peaks of respiratory illness. Am J Epidemiol 1969;89:184-196.
99. Hewson CA, Haas JJ, Bartlett NW, et al. Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-kappaB and EGFR pathways. Eur Respir J 2010;36:1425-1435.
100. Heymann PW, Carper HT, Murphy DD, et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 2004;114:239-247.
101. Heymann PW, Platts-Mills TA, Johnston SL. Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults. Pediatr Infect Dis J 2005;24:S217-S222.
102. Hicks LA, Shepard CW, Britz PH, et al. Two outbreaks of severe respiratory disease in nursing homes associated with rhinovirus. J Am Geriatr Soc 2006;54:284-289.
103. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007;120:1233-1244.
104. Holmes MJ, Reed SE, Stott EJ, et al. Studies of experimental rhinovirus type 2 infections in polar isolation and in England. J Hyg (Lond) 1976;76:379-393.
105. Horn MEC, Brain E, Gregg I, et al. Respiratory viral infection in childhood. A survey in general practice, Roehampton 1967-1972. J Hyg (Lond) 1975;74:157-168.
106. Horn MEC, Reed SE, Taylor P. Role of viruses and bacteria in acute wheezy bronchitis in childhood: a study of sputum. Arch Dis Child 1979;54:587-592.
107. Huang T, Wang W, Bessaud M, et al. Evidence of recombination and genetic diversity in human rhinoviruses in children with acute respiratory infection. PLoS One 2009;4:e6355.
108. Huguenel ED, Cohn D, Dockum DP, et al. Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1. Am J Respir Crit Care Med 1997;155:1206-1210.
109. Hyypiä T, Puhakka T, Ruuskanen O, et al. Molecular diagnosis of human rhinovirus infections: Comparison with virus isolation. J Clin Microbiol 1998;36:2081-2083.
110. Igarashi Y, Skoner DP, Doyle WJ, et al. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J Allergy Clin Immunol 1993;92:722-731.
111. Ireland DC, Kent J, Nicholson KG. Improved detection of rhinoviruses in nasal and throat swabs by seminested RT-PCR. J Med Virol 1993;40:96-101.
112. Ison MG, Hayden FG, Kaiser L, et al. Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. Clin Infect Dis 2003;36:1139-1143.
113. Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008;178:667-672.
114. Jackson RJ. Initiation site selection mechanisms. In: Mathews MB, Sonenberg N, eds. Tranlational Control. Woodbury, NY: Cold Spring Harbor Laboratory Press; 1996:71-112.
115. Jacques J, Bouscambert-Duchamp M, Moret H, et al. Association of respiratory picornaviruses with acute bronchiolitis in French infants. J Clin Virol 2006;35:463-466.
116. Jakiela B, Brockman-Schneider R, Amineva S, et al. Basal cells of differentiated bronchial epithelium are more susceptible to rhinovirus infection. Am J Respir Cell Mol Biol 2008;38:517-523.
117. Jang YJ, Kwon HJ, Park HW, et al. Detection of rhinovirus in turbinate epithelial cells of chronic sinusitis. Am J Rhinol 2006;20:634-636.
118. Jarjour NN, Gern JE, Kelly EA, et al. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol 2000;105:1169-1177.
119. Jartti T, Lee WM, Pappas T, et al. Serial viral infections in infants with recurrent respiratory illnesses. Eur Respir J 2008;32:314-320.
120. Jartti T, Lehtinen P, Vuorinen T, et al. Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol 2004;72:695-699.
121. Jartti T, Lehtinen P, Vuorinen T, et al. Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis 2004;10:1095-1101.
122. Jartti T, Lehtinen P, Vuorinen T, et al. Bronchiolitis: age and previous wheezing episodes are linked to viral etiology and atopic characteristics. Pediatr Infect Dis J 2009;28:311-317.
123. Jartti T, Paul-Anttila M, Lehtinen P, et al. Systemic T-helper and T-regulatory cell type cytokine responses in rhinovirus vs. respiratory syncytial virus induced early wheezing: an observational study. Respir Res 2009;10:85.
124. Jennings LC, Dick EC. Transmission and control of rhinovirus colds. Eur J Epidemiol 1987;3:327-335.
125. Johnston NW, Johnston SL, Duncan JM, et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 2005;115:132-138.
126. Johnston NW, Johnston SL, Norman GR, et al. The September epidemic of asthma hospitalization: school children as disease vectors. J Allergy Clin Immunol 2006;117:557-562.
127. Johnston SL, Papi A, Monick MM, et al. Rhinoviruses induce interleukin-8 mRNA and protein production in human monocytes. J Infect Dis 1997;175:323-329.
128. Johnston SL, Pattemore PK, Sanderson G, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time trend analysis. Am J Respir Crit Care Med 1996;154:654-660.
129. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:1225-1229.
130. Kainulainen L, Vuorinen T, Rantakokko-Jalava K, et al. Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 2010;126:120-126.
131. Khaitov MR, Laza-Stanca V, Edwards MR, et al. Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy 2009;64:375-386.
132. Kim J, Sanders SP, Siekierski ES, et al. Role of NF-kappa B in cytokine production induced from human airway epithelial cells by rhinovirus infection. J Immunol 2000;165:3384-3392.
133. Kistler AL, Webster DR, Rouskin S, et al. Genome-wide diversity and selective pressure in the human rhinovirus. Virol J 2007;4:40.
134. Kloepfer KM, DeMore JP, Vrtis RF, et al. Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16. Ann Allergy Asthma Immunol 2011;106:252-257.
135. Konno S, Grindle KA, Lee WM, et al. Interferon-γ enhances rhinovirus-induced RANTES secretion in human airway epithelial cells. Am J Respir Cell Mol Biol 2002;26:594-601.
136. Korpi-Steiner NL, Bates ME, Lee WM, et al. Human rhinovirus induces robust IP-10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and STAT1 activation. J Leukoc Biol 2006;80:1364-1374.
137. Korpi-Steiner NL, Valkenaar SM, Bates ME, et al. Human monocytic cells direct the robust release of CXCL10 by bronchial epithelial cells during rhinovirus infection. Clin Exp Allergy 2010;40:1203-1213.
138. Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM, et al. Rhinovirus-induced wheezing in infancy-the first sign of childhood asthma? J Allergy Clin Immunol 2003;111:66-71.
139. Kruse W. The etiology of cough and nasal catarrh. Munchener medizinische Wochenschuft 1914;61:1574.
140. Kuo C, Lim S, King NJ, et al. Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo. Respirology 2011;16:367-377.
141. Kusel MM, de Klerk NH, Holt PG, et al. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J 2006;25:680-686.
142. Kusel MM, de Klerk NH, Kebadze T, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007;119:1105-1110.
143. Lachowicz-Scroggins ME, Boushey HA, Finkbeiner WE, et al. Interleukin-13 induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection. Am J Respir Cell Mol Biol 2010;43:652-661.
144. Lau C, Wang X, Song L, et al. Syk associates with clathrin and mediates phosphatidylinositol 3-kinase activation during human rhinovirus internalization. J Immunol 2008;180:870-880.
145. Lau SK, Yip CC, Tsoi HW, et al. Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol 2007;45:3655-3664.
146. Laza-Stanca V, Stanciu LA, Message SD, et al. Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production. J Virol 2006;80:8248-8258.
147. Lee WM, Grindle KA, Pappas TE, et al. A high-throughput, sensitive and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses. J Clin Microbiol 2007;45:2626-2634.
148. Lee WM, Kiesner C, Pappas T, et al. A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLoS One 2007;2:e966.
149. Legg JP, Warner JA, Johnston SL, et al. Frequency of detection of picornaviruses and seven other respiratory pathogens in infants. Pediatr Infect Dis J 2005;24:611-616.
150. Lemanske RF Jr, Jackson DJ, Gangnon RE, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 2005;116:571-577.
151. Levandowski RA, Ou DW, Jackson GG. Acute-phase decrease of T lymphocyte subsets in rhinovirus infection. J Infect Dis 1986;153:743-748.
152. Levandowski RA, Pachucki CT, Rubenis M. Specific mononuclear cell response to rhinovirus. J Infect Dis 1983;148:1125.
153. Linsuwanon P, Payungporn S, Samransamruajkit R, et al. High prevalence of human rhinovirus C infection in Thai children with acute lower respiratory tract disease. J Infect 2009;59:115-121
154. Lopez-Souza N, Dolganov G, Dubin R, et al. Resistance of differentiated human airway epithelium to infection by rhinovirus. Am J Physiol Lung Cell Mol Physiol 2004;286:L373-L381.
155. Lopez-Souza N, Favoreto S, Wong H, et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol 2009;123:1384-1390.
156. Mackay IM. Human rhinoviruses: the cold wars resume. J Clin Virol 2008;42:297-320.
157. Makela MJ, Puhakka T, Ruuskanen O, et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 1998;36:539-542.
158. Malmstrom K, Pitkaranta A, Carpen O, et al. Human rhinovirus in bronchial epithelium of infants with recurrent respiratory symptoms. J Allergy Clin Immunol 2006;118:591-596.
159. Marlin SD, Staunton DE, Springer TA, et al. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature 1990;344:70-72.
160. McBride TP, Doyle WJ, Hayden FG, et al. Alterations of the eustachian tube, middle ear, and nose in rhinovirus infection. Arch Otolaryngol Head Neck Surg 1989;115:1054-1059.
161. McErlean P, Shackelton LA, Andrews E, et al. Distinguishing molecular features and clinical characteristics of a putative new rhinovirus species, human rhinovirus C (HRV C). PLoS One 2008;3:e1847.
162. McErlean P, Shackelton LA, Lambert SB, et al. Characterisation of a newly identified human rhinovirus, HRV-QPM, discovered in infants with bronchiolitis. J Clin Virol 2007;39:67-75.
163. McFadden ER Jr, Pichurko BM, Bowman HF, et al. Thermal mapping of the airways in humans. J Appl Physiol 1985;58:564-570.
164. McIntyre CL, William Leitch EC, Savolainen-Kopra C, et al. Analysis of genetic diversity and sites of recombination in human rhinovirus species C. J Virol 2010;84:10297-10310.
165. Meschievitz CK, Schultz SB, Dick EC. A model for obtaining predictable natural transmission of rhinoviruses in human volunteers. J Infect Dis 1984;150:195-201.
166. Miller EK, Edwards KM, Weinberg GA, et al. A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol 2009;123:98-104.
167. Miller EK, Lu X, Erdman DD, et al. Rhinovirus-associated hospitalizations in young children. J Infect Dis 2007;195:773-781.
168. Miller EK, Williams JV, Gebretsadik T, et al. Host and viral factors associated with severity of human rhinovirus-associated infant respiratory tract illness. J Allergy Clin Immunol 2011;127:883-891.
169. Miron D, Srugo I, Kra-Oz Z, et al. Sole pathogen in acute bronchiolitis: is there a role for other organisms apart from respiratory syncytial virus? Pediatr Infect Dis J 2010;29:e7-e10.
170. Monto AS, Bryan ER, Ohmit S. Rhinovirus infections in Tecumseh, Michigan: Frequency of illness and number of serotypes. J Infect Dis 1987;156:43-49.
171. Monto AS, Cavallaro JJ. The Tecumseh study of respiratory illness. IV. Prevalence of rhinovirus serotypes, 1966-1969. Am J Epidemiol 1972;96:352-360.
172. Monto AS, Johnson KM. A community study of respiratory infections in the tropics. II. The spread of six rhinovirus isolates within the community. Am J Epidemiol 1968;88:55-68.
173. Moody SA, Alper CM, Doyle WJ. Daily tympanometry in children during the cold season: association of otitis media with upper respiratory tract infections. Int J Pediatr Otorhinolaryngol 1998;45:143-150.
174. Mosser AG, Brockman-Schneider RA, Amineva SP, et al. Similar frequency of rhinovirus-infectable cells in upper and lower airway epithelium. J Infect Dis 2002;185:734-743.
175. Mosser AG, Vrtis R, Burchell L, et al. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med 2005;171:645-651.
176. Muether PS, Gwaltney JM Jr. Variant effect of first- and second-generation antihistamines as clues to their mechanism of action on the sneeze reflex in the common cold. Clin Infect Dis 2001;33:1483-1488.
177. Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006;61:376-382.
178. Nagarkar DR, Bowman ER, Schneider D, et al. Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages. J Immunol 2010;185:2525-2535.
179. Newcomb DC, Sajjan U, Nanua S, et al. PI 3-kinase is required for rhinovirus-induced airway epithelial cell IL-8 expression. J Biol Chem 2005;280(44):36952-36961.
180. Newcomb DC, Sajjan US, Nagarkar DR, et al. Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice. Am J Respir Crit Care Med 2008;177:1111-1121.
181. Nicholson KG, Kent J, Hammersley V, et al. Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study. BMJ 1996;313:1119-1123.
182. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982-986.
183. Ohlin A, Hooverlitty H, Sanderson G, et al. Spectrum of activity of soluble intercellular adhesion molecule- 1 against rhinovirus reference strains and field isolates. Antimicrob Agents Chemother 1994;38:1413-1415.
184. Olenec JP, Kim WK, Lee WM, et al. Weekly monitoring of children with asthma for infections and illness during common cold seasons. J Allergy Clin Immunol 2010;125:1001-1006.
185. Palmenberg AC, Rathe JA, Liggett SB. Analysis of the complete genome sequences of human rhinovirus. J Allergy Clin Immunol 2010;125:1190-1199.
186. Palmenberg AC, Spiro D, Kuzmickas R, et al. Sequencing and analyses of all known human rhinovirus genomes reveals structure and evolution. Science 2009;324:55-59.
187. Papadopoulos NG, Bates PJ, Bardin PG, et al. Rhinoviruses infect the lower airways. J Infect Dis 2000;181:1875-1884.
188. Parry DE, Busse WW, Sukow KA, et al. Rhinovirus-induced peripheral blood mononuclear cell responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol 2000;105:692-698.
189. Paul IM, Beiler JS, King TS, et al. Vapor rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms. Pediatr 2010;126:1092-1099.
190. Pelon W, Mogabgab WJ, Phillips IA, et al. A cytopathogenic agent isolated from naval recruits with mild respiratory illnesses. Proc Soc Exp Biol Med 1957;94:262-267.
191. Peltola V, Waris M, Osterback R, et al. Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections. J Infect Dis 2008;197:382-389.
192. Perkins JC, Tucker DN, Knopf HL, et al. Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness. Am J Epidemiol 1969;90:519-526.
193. Piralla A, Rovida F, Campanini G, et al. Clinical severity and molecular typing of human rhinovirus C strains during a fall outbreak affecting hospitalized patients. J Clin Virol 2009;45:311-317.
194. Pitkaranta A, Arruda E, Malmberg H, et al. Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR. J Clin Microbiol 1997;35:1791-1793.
195. Pitkaranta A, Puhakka T, Makela MJ, et al. Detection of rhinovirus RNA in middle turbinate of patients with common colds by in situ hybridization. J Med Virol 2003;70:319-323.
196. Pitkäranta A, Virolainen A, Jero J, et al. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatr 1998;102:291-295.
197. Powell KR, Shorr R, Cherry JD, et al. Improved method for collection of nasal mucus. J Infect Dis 1977;136:109-111.
198. Price WH. The isolation of a new virus associated with respiratory clinical disease in humans. Proc Natl Acad Sci U S A 1956;42:892-896.
199. Proud D, Gwaltney JM. Jr, Hendley JO, et al. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis 1994;169:1007-1013.
200. Proud D, Naclerio RM, Gwaltney JM, et al. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis 1990;161:120-123.
201. Proud D, Sanders SP, Wiehler S. Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo. J Immunol 2004;172:4637-4645.
202. Proud D, Turner RB, Winther B, et al. Gene expression profiles during in vivo human rhinovirus infection: insights into the host response. Am J Respir Crit Care Med 2008;178:962-968.
203. Puhakka T, Makela MJ, Alanen A, et al. Sinusitis in the common cold. J Allergy Clin Immunol 1998;102:403-408.
204. Rakes GP, Arruda E, Ingram JM, et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med 1999;159:785-790.
205. Rankl C, Kienberger F, Wildling L, et al. Multiple receptors involved in human rhinovirus attachment to live cells. Proc Natl Acad Sci U S A 2008;105:17778-17783.
206. Rosenthal LA, Amineva SP, Szakaly RJ, et al. A rat model of picornavirus-induced airway infection and inflammation. Virol J 2009;6:122.
207. Sajjan U, Wang Q, Zhao Y, et al. Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am J Respir Crit Care Med 2008;178:1271-1281.
208. Sanders SP, Siekierski ES, Porter JD, et al. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol 1998;72:934-942.
209. Sanu A, Eccles R. The effects of a hot drink on nasal airflow and symptoms of common cold and flu. Rhinology 2008;46:271-275.
210. Savolainen C, Blomqvist S, Mulders MN, et al. Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70. J Gen Virol 2002;83:333-340.
211. Savolainen-Kopra C, Blomqvist S, Kilpi T, et al. Novel species of human rhinoviruses in acute otitis media. Pediatr Infect Dis J 2009;28:59-61.
212. Sedgwick JB, Menon I, Gern JE, et al. Effects of inflammatory cytokines on the permeability of human lung microvascular endothelial cell monolayers and differential eosinophil transmigration. J Allergy Clin Immunol 2002;110:752-756.
213. Shepard DA, Heinz BA, Rueckert RR. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14. J Virol 1993;67:2245-2254.
214. Sheppard D, Rizk NW, Boushey HA, et al. Mechanism of cough and bronchoconstriction induced by distilled water aerosol. Am Rev Respir Dis 1983;127:691-694.
215. Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood [see comments]. Science 1999;284:1835-1837.
216. Simmonds P, McIntyre C, Savolainen-Kopra C, et al. Proposals for the classification of human rhinovirus species C into genotypically assigned types. J Gen Virol 2010;91:2409-2419.
217. Simons E, Schroth MK, Gern JE. Analysis of tracheal secretions for rhinovirus during natural colds. Pediatr Allergy Immunol 2005;16:276-278.
218. Singh AM, Moore PE, Gern JE, et al. Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation. Am J Respir Crit Care Med 2007;175:108-119.
219. Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev 2011:CD001364.
220. Slater L, Bartlett NW, Haas JJ, et al. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog 2010;6:e1001178.
221. Slavin RG, Spector SL, Bernstein IL, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005;116:S13-S47.
222. Smyth AR, Smyth RL, Tong CYW, et al. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child 1995;73:117-120.
223. Spurrell JC, Wiehler S, Zaheer RS, et al. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2005;289:L85-L95.
224. Spyridaki IS, Christodoulou I, de BL, et al. Comparison of four nasal sampling methods for the detection of viral pathogens by RT-PCR-A GA(2)LEN project. J Virol Methods 2009;156:102-106.
225. Steil BP, Barton DJ. Cis-active RNA elements (CREs) and picornavirus RNA replication. Virus Res 2009;139:240-252.
226. Stone AA, Bovbjerg DH, Neale JM, et al. Development of common cold symptoms following experimental rhinovirus infection is related to prior stressful life events. Behav Med 1992;18:115-120.
227. Sung BS, Chonmaitree T, Broemeling LD, et al. Association of rhinovirus infection with poor bacteriologic outcome of bacterial-viral otitis media. Clin Infect Dis 1993;17:38-42.
228. Tapparel C, L'Huillier AG, Rougemont AL, et al. Pneumonia and pericarditis in a child with HRV-C infection: a case report. J Clin Virol 2009;45:157-160.
229. Taylor-Robinson D. Studies on some viruses (rhinoviruses) isolated from common colds. Arch Gesamte Virusforsch 1963;13:281-293.
230. Teran LM, Johnston SL, Schroder JM, et al. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am J Respir Crit Care Med 1997;155:1362-1366.
231. Turner RB. The role of neutrophils in the pathogenesis of rhinovirus infections. Pediatr Infect Dis J 1990;9:832-835.
232. Turner RB. New considerations in the treatment and prevention of rhinovirus infections. Pediatr Ann 2005;34:53-57.
233. Turner RB, Bauer R, Woelkart K, et al. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med 2005;353:341-348.
234. Turner RB, Dutko FJ, Goldstein NH, et al. Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection. Antimicrob Agents Chemother 1993;37:297-300.
235. Turner RB, Weingand KW, Yeh CH, et al. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis 1998;26:840-846.
236. Tuthill TJ, Papadopoulos NG, Jourdan P, et al. Mouse respiratory epithelial cells support efficient replication of human rhinovirus. J Gen Virol 2003;84:2829-2836.
237. Tyrrell DA. The common cold-my favourite infection. The eighteenth Majority Stephenson memorial lecture. J Gen Virol 1987;68(Pt 8):2053-2061.
238. van der Zalm MM, Uiterwaal CS, Wilbrink B, et al. Respiratory pathogens in respiratory tract illnesses during the first year of life: a birth cohort study. Pediatr Infect Dis J 2009;28:472-476.
239. van der Zalm MM, Uiterwaal CS, Wilbrink B, et al. The influence of neonatal lung function on rhinovirus-associated wheeze. Am J Respir Crit Care Med 2011;183:262-267.
240. van der Zalm MM, van Ewijk BE, Wilbrink B, et al. Respiratory pathogens in children with and without respiratory symptoms. J Pediatr 2009;154:396-400.
241. Venarske DL, Busse WW, Griffin MR, et al. The relationship of rhinovirus-associated asthma hospitalizations with inhaled corticosteroids and smoking. J Infect Dis 2006;193:1536-1543.
242. Vlasak M, Goesler I, Blaas D. Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment. J Virol 2005;79:5963-5970.
243. Vlasak M, Roivainen M, Reithmayer M, et al. The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of a lysine in the VP1 HI loop is not sufficient for receptor binding. J Virol 2005;79:7389-7395.
244. Wang Q, Nagarkar DR, Bowman ER, et al. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J Immunol 2009;183:6989-6997.
245. Wang X, Lau C, Wiehler S, et al. Syk is downstream of intercellular adhesion molecule-1 and mediates human rhinovirus activation of p38 MAPK in airway epithelial cells. J Immunol 2006;177:6859-6870.
246. Wark PA, Bucchieri F, Johnston SL, et al. IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J Allergy Clin Immunol 2007;120:586-593.
247. Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005;201:937-947.
248. Warshauer DM, Dick EC, Mandel AD, et al. Rhinovirus infections in an isolated Antarctic station: Transmission of the viruses and susceptibility of the population. Am J Epidemiol 1989;129:319-340.
249. Wat D, Gelder C, Hibbitts S, et al. The role of respiratory viruses in cystic fibrosis. J Cyst Fibros 2008;7:320-328.
250. Whiteman SC, Spiteri MA. IFN-gamma regulation of ICAM-1 receptors in bronchial epithelial cells: soluble ICAM-1 release inhibits human rhinovirus infection. J Inflamm (Lond) 2008;5:8.
251. Widegren H, Andersson M, Borgeat P, et al. LTB4 increases nasal neutrophil activity and conditions neutrophils to exert antiviral effects. Respir Med 2011;105:997-1006.
252. Winther B, Alper CM, Mandel EM, et al. Temporal relationships between colds, upper respiratory viruses detected by polymerase chain reaction, and otitis media in young children followed through a typical cold season. Pediatr 2007;119:1069-1075.
253. Winther B, Brofeldt S, Christensen B, et al. Light and scanning electron microscopy of nasal biopsy material from patients with naturally acquired common colds. Acta Otolaryngol 1984;97:309-318.
254. Winther B, Farr B, Thoner RB, et al. Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol 1984;413(suppl):19-24.
255. Winther B, Greve JM, Gwaltney JMJ, et al. Surface expression of intercellular adhesion molecule 1 on epithelial cells in the human adenoid. J Infect Dis 1997;176:523-525.
256. Winther B, Gwaltney JM Jr, Mygind M, et al. Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA 1986;256:1763-1767.
257. Winther B, Hayden FG, Hendley JO. Picornavirus infections in children diagnosed by RT-PCR during longitudinal surveillance with weekly sampling: Association with symptomatic illness and effect of season. J Med Virol 2006;78:644-650.
258. Wiselka MJ, Kent J, Cookson JB, et al. Impact of respiratory virus infection in patients with chronic chest disease. Epidemiol Infect 1993;111:337-346.
259. Wood LG, Powell H, Grissell TV, et al. Persistence of rhinovirus RNA and IP-10 gene expression after acute asthma. Respirology 2011;16:291-299.
260. Xatzipsalti M, Kyrana S, Tsolia M, et al. Rhinovirus viremia in children with respiratory infections. Am J Respir Crit Care Med 2005;172(8):1037-1040.
261. Yin FH, Lomax NB. Establishment of a mouse model for human rhinovirus infection. J Gen Virol 1986;67:2335-2340.
262. Yuta A, Doyle WJ, Gaumond E, et al. Rhinovirus infection induces mucus hypersecretion. Am J Physiol Lung Cell Mol Physiol 1998;274:L1017-L1023.
263. Zaheer RS, Proud D. Human rhinovirus-induced epithelial production of CXCL10 is dependent upon IFN regulatory factor-1. Am J Respir Cell Mol Biol 2010;43:413-421.